2.065
price down icon3.50%   -0.075
after-market 시간 외 거래: 2.14 0.075 +3.63%
loading
전일 마감가:
$2.14
열려 있는:
$2.15
하루 거래량:
983.57K
Relative Volume:
0.68
시가총액:
$188.58M
수익:
-
순이익/손실:
$-192.96M
주가수익비율:
-0.6258
EPS:
-3.3
순현금흐름:
$-167.04M
1주 성능:
-14.32%
1개월 성능:
+21.47%
6개월 성능:
-5.71%
1년 성능:
-8.63%
1일 변동 폭
Value
$2.06
$2.195
1주일 범위
Value
$2.05
$2.51
52주 변동 폭
Value
$0.783
$3.39

Ventyx Biosciences Inc Stock (VTYX) Company Profile

Name
명칭
Ventyx Biosciences Inc
Name
전화
(858) 945-2393
Name
주소
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Name
직원
79
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
VTYX's Discussions on Twitter

VTYX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VTYX
Ventyx Biosciences Inc
2.065 188.58M 0 -192.96M -167.04M -3.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-12 업그레이드 Oppenheimer Perform → Outperform
2024-03-12 업그레이드 Wells Fargo Equal Weight → Overweight
2023-11-07 다운그레이드 H.C. Wainwright Buy → Neutral
2023-11-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-11-07 다운그레이드 Oppenheimer Outperform → Perform
2023-11-07 다운그레이드 Stifel Buy → Hold
2023-11-07 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-06-14 재개 Credit Suisse Outperform
2023-03-21 개시 Wells Fargo Overweight
2022-12-19 개시 Goldman Buy
2022-11-17 개시 Morgan Stanley Overweight
2022-09-07 개시 Stifel Buy
2022-09-01 개시 H.C. Wainwright Buy
2022-05-09 개시 Credit Suisse Outperform
2022-03-31 개시 Canaccord Genuity Buy
2022-02-01 개시 Oppenheimer Outperform
2021-11-15 개시 Jefferies Buy
2021-11-15 개시 Piper Sandler Overweight
모두보기

Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스

pulisher
Jun 18, 2025

Ventyx stock steady as Parkinson’s drug shows biomarker reductions By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Ventyx reports positive outcomes from trial of VTX3232 for Parkinson’s - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Inc’s Mixed Bag: Down -9.22% in 6 Months, Down 58.21% in 30 Days - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Top-Line Data from - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Shares Fall After Tier 2 Exploratory Biomarkers Remain Stable in Parkinson's Study - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx reports positive Phase 2a results for Parkinson’s drug - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Insiders Placed Bullish Bets Worth US$1.26m - Yahoo

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences' Study of VTX3232 Met Safety, Tolerability Objectives - MarketWatch

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx posts mid-stage trial win for Parkinson’s drug (VTYX) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences stock trades flat despite positive parkinson’s drug trial data - Investing.com Canada

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson'S Disease - marketscreener.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx Biosciences Announces Positive Data From Its Phase 2A Trial Evaluating Vtx3232 In Patients With Early-Stage Parkinson’S Disease - TradingView

Jun 17, 2025
pulisher
Jun 17, 2025

Ventyx reports positive Phase 2a results for Parkinson’s drug By Investing.com - Investing.com India

Jun 17, 2025
pulisher
Jun 17, 2025

VTYX Trading Halted as Market Awaits News Update | VTYX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 15, 2025

Piper Sandler maintains $21 target on Ventyx stock By Investing.com - Investing.com Nigeria

Jun 15, 2025
pulisher
Jun 12, 2025

Traders Buy Large Volume of Ventyx Biosciences Call Options (NASDAQ:VTYX) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Ventyx Biosciences reports annual meeting results By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Ventyx Biosciences reports annual meeting results - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

Piper Sandler maintains $21 target on Ventyx stock - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

As Ventyx Approaches Multiple Phase II Readouts, What Could Be Next For The Stock? - RTTNews

Jun 09, 2025
pulisher
Jun 09, 2025

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Has $1.04 Million Stock Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ventyx Biosciences at Jefferies Conference: Strategic Developments in Focus By Investing.com - Investing.com Canada

Jun 06, 2025
pulisher
Jun 01, 2025

Millennium Management LLC Purchases 1,008,760 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Buys 19,982 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Ventyx Biosciences Executives Set for Key Presentation on Autoimmune Drug Pipeline at Jefferies Conference - Stock Titan

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Takes Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 28, 2025
pulisher
May 25, 2025

Bank of America Corp DE Has $9.36 Million Holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 25, 2025
pulisher
May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025
pulisher
May 21, 2025

Spotlight On 3 Penny Stocks With Market Caps Under $500M - simplywall.st

May 21, 2025
pulisher
May 21, 2025

VTYX LAWSUIT ALERT: Levi & Korsinsky Notifies Ventyx Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

May 21, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Sells 13,616 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 19, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Makes New $347,000 Investment in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 17, 2025
pulisher
May 13, 2025

Barclays PLC Boosts Stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 13, 2025
pulisher
May 11, 2025

VTYX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Ventyx Biosciences, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

May 11, 2025
pulisher
May 10, 2025

Mariner LLC Sells 8,485 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Ventyx Biosciences Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Investors who lost money on Ventyx Biosciences, Inc. (VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Lost Money on Ventyx Biosciences, Inc.(VTYX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders of Ventyx Biosciences, Inc. Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Market Resilience: Ventyx Biosciences Inc (VTYX) Finishes Weak at 1.28, Down -5.88 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Ventyx Biosciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders that lost money on Ventyx Biosciences, Inc.(VTYX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ventyx Biosciences, Inc. - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Ratios Uncovered: Breaking Down Ventyx Biosciences Inc (VTYX)’s Trailing Twelve Months Metrics - DWinneX

May 07, 2025
pulisher
May 05, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 05, 2025

Ventyx Biosciences Inc (VTYX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Ventyx Biosciences Inc 주식 (VTYX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Mohan Raju
CEO AND PRESIDENT
Mar 28 '25
Option Exercise
0.00
11,844
0
2,303,540
Nuss John
CHIEF SCIENTIFIC OFFICER
Mar 28 '25
Option Exercise
0.00
4,531
0
469,113
Nuss John
CHIEF SCIENTIFIC OFFICER
Dec 27 '24
Sale
2.36
21,119
49,841
464,582
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):